Skip to content

Comparison of sodium valporate and midazolam in children status epilepticus

Comparison of continuous infusion of sodium valporate and midazolam in children status epilepticus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201206101808N4
Enrollment
70
Registered
2016-02-14
Start date
2014-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

status epilepticus. Status epilepticus

Interventions

Intervention 1: Intervention: valproate Loading: 20mg/kg, then 20-30mg/kg/24 hr. Intervention 2: Control: midazolam Loading: 0/15mg/kg, then 1-6µg/kg/min.
Treatment - Drugs
Intervention: valproate Loading: 20mg/kg, then 20-30mg/kg/24 hr
Control: midazolam Loading: 0/15mg/kg, then 1-6µg/kg/min

Sponsors

Research Center of Mazandaran University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Months to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Minimum age 3 month and maximum 14 years old ; Absence of renal or hepatic disfunction, shock, atrial or ventricular block ; No drug history of valproate or midazolam therapy in control of status epilepticus ; Normal range of CBC, BS,Ca, Na, K, BUN, Cr, SGOT, SGPT at beginning of treatment ; No control of status epilepticus with first line drugs such as diazepam, Phenytoin and Phenobarbital. exclusion criteria: all children with acute or chronic liver disease ; all children with metabolic disease ; seizure in children with trauma ; all children with coagulation disfunction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Status epilepticus treatment. Timepoint: before prevention and 24 hours after prevention. Method of measurement: questionarie.

Secondary

MeasureTime frame
Complications of treatment. Timepoint: during first 72 hours of prevention. Method of measurement: questionarie.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMotahareh Kheradmand

Mazandaran Univercity of Medical sciences and Health ervices

kheradmand@mazums.ac.ir00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026